Breaking News
Get 50% Off 0
🤫 Unfair Advantage: 10 bargain stocks found using this simple tool
See undervalued stocks

Zacks Investment Research Zacks Investment Research

Zacks Investment Research's Opinion & Analysis.
Featured here: a complete archive of all posts and research produced by Zacks Investment Research, including current material.
Best Income Stocks to Buy for January 19th By Zacks Investment Research - Jan 19, 2022

Here are three stocks with buy rank and strong income characteristics for investors to consider today, January 19th:Ready Capital (NYSE:RC) Corp RC: This publicly-traded mortgage REIT has witnessed...

Should Value Investors Consider Ross Stores (ROST) Stock? By Zacks Investment Research - Jan 19, 2022

Value investing is easily one of the most popular ways to find great stocks in any market environment. After all, who wouldn’t want to find stocks that are either flying under the radar and are...

Here's Why You Should Invest in Consumer Staples ETFs By Zacks Investment Research - Jan 19, 2022

Wall Street has had a rough start to 2022 as continued weakness is being observed on the bourses. The Dow Jones Industrial Average lost 1.5% on Jan 18. The other two broad market indices, the S&P...

There's Always a Bull Market Somewhere By Zacks Investment Research - Jan 19, 2022

(0:30) - Where Is The Bull Market Heading In 2022?(4:00) - Is It Too Good To Be True: Fraud Problems(12:45) - Stock Screener For Strong Stocks: Don’t Fight The Fed(24:00) - Episode Roundup: WPC,...

Top Research Reports for Roche, Anthem & Infosys By Zacks Investment Research - Jan 19, 2022

Wednesday, January 19, 2022The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Roche...

Why Is Nike (NKE) Down 11.8% Since Last Earnings Report? By Zacks Investment Research - Jan 18, 2022

It has been about a month since the last earnings report for Nike (NYSE:NKE). Shares have lost about 11.8% in that time frame, underperforming the S&P 500.Will the recent negative trend continue...

Will 2022 Be a Better Year for Biotech Than 2021? 3 Big Picks By Zacks Investment Research - Jan 18, 2022

Despite the success of COVID vaccines and medicines, the biotech sector underperformed the broader market in 2021. The Medical-Biomedical and Genetics industry declined 21.6% in 2021 against the...

BofA (BAC) Up as Q4 Earnings Beat on M&A Fees, Solid Lending By Zacks Investment Research - Jan 18, 2022

Bank of America’s BAC fourth-quarter 2021 earnings of 82 cents per share beat the Zacks Consensus Estimate of 76 cents. The bottom line compared favorably with 59 cents earned in the prior-year...

Fulton Financial (FULT) Q4 Earnings Meet Estimates By Zacks Investment Research - Jan 18, 2022

Fulton Financial (NASDAQ:FULT) came out with quarterly earnings of $0.37 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.30 per share a year ago. These figures...

Bull of the Day: KB Home (KBH) By Zacks Investment Research - Jan 18, 2022

KB Home (NYSE:KBH) KBH continues to see strong demand for new homes and is able to navigate supply chain challenges heading into 2022. This Zacks Rank #1 (Strong Buy) is expected to grow earnings by...

Continue with Apple
Continue with Google
or
Sign up with Email